DPP7

Across TCGA pan-cancer cohorts, DPP7 Mutation is linked to patient survival in 5 of 34 cancer types, making it a survival-associated DPP7 data layer compared with 27 for mass-spec protein and 6 for mass-spec protein.

The strongest signal is observed in esophageal carcinoma (ESCA), where higher DPP7 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated DPP7 expression acts as an unfavorable survival marker, although some lineages such as SKCM show a favorable association.

ESCA, LUAD, and UCEC are the cancer types where DPP7 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ESCA	OS	Median	II,III,IV	0.117	0.703	<.001	36	view →
LUAD	DFS	Median	All	0.036	0.791	<.001	18	view →
UCEC	OS	Median	IV	0.231	0.592	.036	6	view →
LUSC	DFS	Median	All	0.350	0.663	.023	6	view →
SKCM	DFS	Median	All	0.692	0.198	.036	1	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

DPP7–ESCA (OS)

Open the ESCA breakdown →